Currency In USD
| Previous Close | 0.75 |
| Open | 0.75 |
| Day High | 0.75 |
| Day Low | 0.73 |
| 52-Week High | 1.89 |
| 52-Week Low | 0.36 |
| Volume | 60,430 |
| Average Volume | 390,609 |
| Market Cap | 15.6M |
| PE | -0.95 |
| EPS | -0.79 |
| Moving Average 50 Days | 0.7 |
| Moving Average 200 Days | 0.7 |
| Change | -0 |
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant
Newsfile
Mar 11, 2026 12:00 PM GMT
First Cochlear Implant Company to Announce Completed Enrollment of a U.S. Pivotal Clinical Trial for a Fully Implanted Cochlear Implant seeking FDA ApprovalWhite Bear Lake, Minnesota--(Newsfile Corp. - March 11, 2026) - Envoy Medical® Inc. (NASDAQ: C
Envoy Medical Regains Compliance with Nasdaq Listing Requirement
Newsfile
Feb 24, 2026 1:00 PM GMT
White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has received writ
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space
Newsfile
Feb 23, 2026 1:00 PM GMT
White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of three new